Get started
EXELIXIS INC COM STK USD0.001EXELIXIS INC COM STK USD0.001EXELIXIS INC COM STK USD0.001

EXELIXIS INC COM STK USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0IJO chart


Full chart

0IJO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.12 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
20.5
Basic EPS (TTM)
1.8 USD
Net income (FY)
‪521.27 M‬ USD
Revenue (FY)
‪2.17 B‬ USD
Shares float
‪270.46 M‬
Beta (1Y)
0.30

Employees


Employees (FY)
‪1.15 K‬
Change (1Y)
−163 −12.44%
Revenue / Employee (1Y)
‪1.89 M‬ USD
Net income / Employee (1Y)
‪454.46 K‬ USD

About Exelixis, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Michael M. Morrissey
Website
exelixis.com
Headquarters
Alameda
Founded
1994
FIGI
BBG00JVXCWB5
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0IJO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where 0IJO is featured.

See all sparks 


Check out other big names from the same industry as 0IJO.

Frequently Asked Questions


The current price of 0IJO is 36.2 USD — it has decreased by −0.37% in the past 24 hours. Watch EXELIXIS INC COM STK USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange EXELIXIS INC COM STK USD0.001 stocks are traded under the ticker 0IJO.
0IJO stock has risen by 3.60% compared to the previous week, the month change is a −2.00% fall, over the last year EXELIXIS INC COM STK USD0.001 has showed a 57.40% increase.
We've gathered analysts' opinions on EXELIXIS INC COM STK USD0.001 future price: according to them, 0IJO price has a max estimate of 45.00 USD and a min estimate of 29.00 USD. Watch 0IJO chart and read a more detailed EXELIXIS INC COM STK USD0.001 stock forecast: see what analysts think of EXELIXIS INC COM STK USD0.001 and suggest that you do with its stocks.
0IJO reached its all-time high on Mar 10, 2025 with the price of 40.0 USD, and its all-time low was 14.1 USD and was reached on Oct 25, 2018. View more price dynamics on 0IJO chart.
See other stocks reaching their highest and lowest prices.
0IJO stock is 1.10% volatile and has beta coefficient of 0.30. Track EXELIXIS INC COM STK USD0.001 stock price on the chart and check out the list of the most volatile stocks — is EXELIXIS INC COM STK USD0.001 there?
Today EXELIXIS INC COM STK USD0.001 has the market capitalization of ‪10.13 B‬, it has increased by 3.40% over the last week.
Yes, you can track EXELIXIS INC COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
EXELIXIS INC COM STK USD0.001 is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
0IJO earnings for the last quarter are 0.48 USD per share, whereas the estimation was 0.43 USD resulting in a 12.81% surprise. The estimated earnings for the next quarter are 0.36 USD per share. See more details about EXELIXIS INC COM STK USD0.001 earnings.
EXELIXIS INC COM STK USD0.001 revenue for the last quarter amounts to ‪566.75 M‬ USD, despite the estimated figure of ‪564.43 M‬ USD. In the next quarter, revenue is expected to reach ‪496.26 M‬ USD.
0IJO net income for the last quarter is ‪139.86 M‬ USD, while the quarter before that showed ‪117.97 M‬ USD of net income which accounts for 18.55% change. Track more EXELIXIS INC COM STK USD0.001 financial stats to get the full picture.
No, 0IJO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has ‪1.15 K‬ employees. See our rating of the largest employees — is EXELIXIS INC COM STK USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXELIXIS INC COM STK USD0.001 EBITDA is ‪718.75 M‬ USD, and current EBITDA margin is 33.14%. See more stats in EXELIXIS INC COM STK USD0.001 financial statements.
Like other stocks, 0IJO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXELIXIS INC COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXELIXIS INC COM STK USD0.001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXELIXIS INC COM STK USD0.001 stock shows the buy signal. See more of EXELIXIS INC COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.